Naproliquid (Naproxen)

Naproxen works by inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug reduces inflammation, diminishes pain signaling, and helps lower elevated body temperature.

The appropriate dose of Naproliquid is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for naproxen in pregnancy are limited, and the drug is generally avoided, especially in the third trimester, due to potential fetal complications. While limited information exists for breastfeeding, caution is advised because naproxen can be excreted in breast milk. Consultation with a healthcare provider is essential.

To order Naproliquid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naproliquid (naproxen) and ibuprofen are both NSAIDs with similar mechanisms, but naproxen has a longer half‑life, allowing less frequent dosing. Naproxen may provide more sustained pain control, whereas ibuprofen often requires multiple daily doses. Both share comparable efficacy and safety profiles, though individual tolerance and specific clinical scenarios guide selection.

Naproliquid should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat. Do not store in a bathroom or near a kitchen sink where humidity is high.

Naproliquid is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food or an antacid can reduce stomach irritation. Patients should swallow tablets whole and avoid crushing or chewing them unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulcer formation, especially in patients with a history of ulcers or who use anticoagulants. Other critical concerns are acute kidney injury, elevated liver enzymes, severe allergic reactions (anaphylaxis), and increased risk of cardiovascular events such as heart attack or stroke. Prompt medical attention is required if any of these occur.

Naproliquid should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and in late pregnancy. Caution is also advised for patients with uncontrolled hypertension, heart failure, or a history of cardiovascular disease.